Influence of Post-Operative Cyclosporine 0.05% (Restasis) on the Success of Glaucoma Filtering Surgery
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- intraocular pressure
研究概览
简要总结
The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
详细描述
Continued use of glaucoma drops can alter the outer surface of the eye and result in swelling and irritation, changing the structure of the eye. This structural change has been found to be a significant risk factor for the failure of glaucoma surgery. A comparison of how well patients do after glaucoma surgery depending on whether they use Restasis (the only prescription medication approved by the FDA for treating dry eye) or artificial tears (which can be purchased without a prescription) for 6 months following their surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with uncontrolled glaucoma scheduled for filtering surgery
排除标准
- •Under 18 years of age
- •Unable to understand informed consent
研究组 & 干预措施
1
Patients received restasis eyedrops during 6 month post-operative period
干预措施: Restasis (Drug)
2
Patients receive artificial tears (Endura) during 6 month post-operative period
干预措施: Endura (artificial tears) (Drug)
结局指标
主要结局
intraocular pressure
时间窗: 6 months
次要结局
- ocular inflammation(6 months)
研究者
Marlene Moster, MD
Attending Surgeon
Wills Eye